跳至主要内容
临床试验/NCT06288854
NCT06288854Unknown不适用

Efficacy of Olanzapine on Weight Gain in Women with Advanced Stage Gynecologic Cancer Receiving Paclitaxel and Carboplatin Combination Chemotherapy : a Double Blind, Placebo-controlled Randomized Trial

Department of Medical Services Ministry of Public Health of Thailand1 个研究点 分布在 1 个国家目标入组 48 人开始时间: 2024年4月3日最近更新:
适应症

试验速览

阶段
不适用
入组人数
48
试验地点
1
主要终点
Efficacy of olanzapine on weight gain in advanzed stage gynecologic cancer recieving paclitexal and carboplatin chemotherapy

研究概览

简要总结

  • Efficacy of olanzapine on weight gain in advanced stage gynecologic cancer
  • Proprotion of pateints in advanced stage gynecologic cancer who recieving paclitaxel and carboplatin chemotherapy gain weight on olanzapine or placebo

详细描述

-Proprotion of pateints in advanced stage gynecologic cancer who recieving paclitaxel and carboplatin chemotherapy gain weight on olanzapine or placebo

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Advanced stage gynecologic cancer receiving Paclitaxel and carboplatin chemotherapy
  • Normal CBC,Liver, renal function
  • Communication in Thai language or Thai caregiver
  • Inform consent

排除标准

  • Pregnancy
  • Active infection
  • Bowel obstruction or history of bowel surgery
  • On dopamine receptor antagonists or psychiatric or anticonvulsant medication
  • Olanzapine allery
  • Abnormal function of liver and renal
  • Diabetic melitus or morbid obesity
  • patient can't selfcare

结局指标

主要结局

Efficacy of olanzapine on weight gain in advanzed stage gynecologic cancer recieving paclitexal and carboplatin chemotherapy

时间窗: 12 weeks after intervention

proprotion of pateints gain weight after intervention (olanzapine or placebo) by monitor weight before and after get intervention

次要结局

未报告次要终点

研究者

申办方类型
Other Gov
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验